National Health Investors (NHI) Downgraded to “Sell” at Zacks Investment Research

Zacks Investment Research downgraded shares of National Health Investors (NYSE:NHI) from a hold rating to a sell rating in a report released on Friday, Zacks.com reports.

According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

NHI has been the subject of a number of other reports. SunTrust Banks lifted their target price on National Health Investors to $85.00 and gave the stock a neutral rating in a report on Wednesday, February 20th. They noted that the move was a valuation call. KeyCorp set a $65.00 target price on National Health Investors and gave the stock a sell rating in a report on Thursday, December 20th. BMO Capital Markets downgraded National Health Investors from a market perform rating to an underperform rating and set a $78.00 target price for the company. in a report on Wednesday, February 20th. Finally, ValuEngine downgraded National Health Investors from a buy rating to a hold rating in a report on Monday, April 1st. Three investment analysts have rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company. The company presently has a consensus rating of Hold and a consensus price target of $78.14.

Shares of NHI stock opened at $75.02 on Friday. The company has a market capitalization of $3.21 billion, a price-to-earnings ratio of 13.69, a price-to-earnings-growth ratio of 3.42 and a beta of 0.51. The company has a quick ratio of 17.92, a current ratio of 17.92 and a debt-to-equity ratio of 0.92. National Health Investors has a fifty-two week low of $65.10 and a fifty-two week high of $84.57.

National Health Investors (NYSE:NHI) last issued its earnings results on Tuesday, February 19th. The real estate investment trust reported $0.87 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.39 by ($0.52). The business had revenue of $74.00 million during the quarter, compared to the consensus estimate of $75.16 million. National Health Investors had a return on equity of 11.36% and a net margin of 52.38%. The company’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.35 earnings per share. On average, research analysts anticipate that National Health Investors will post 5.48 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Friday, March 29th will be issued a $1.05 dividend. This is an increase from National Health Investors’s previous quarterly dividend of $1.00. This represents a $4.20 dividend on an annualized basis and a yield of 5.60%. The ex-dividend date of this dividend is Thursday, March 28th. National Health Investors’s payout ratio is presently 76.64%.

In other news, Director Robert A. Mccabe, Jr. sold 1,181 shares of the business’s stock in a transaction that occurred on Thursday, February 21st. The stock was sold at an average price of $78.04, for a total transaction of $92,165.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 5.11% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. ERTS Wealth Advisors LLC bought a new stake in shares of National Health Investors during the fourth quarter valued at approximately $25,000. Oppenheimer Asset Management Inc. bought a new stake in shares of National Health Investors during the fourth quarter valued at approximately $52,000. Liberty Wealth Management LLC bought a new stake in shares of National Health Investors during the fourth quarter valued at approximately $69,000. Quantamental Technologies LLC bought a new stake in shares of National Health Investors during the fourth quarter valued at approximately $75,000. Finally, Doyle Wealth Management bought a new stake in shares of National Health Investors during the fourth quarter valued at approximately $76,000. Hedge funds and other institutional investors own 71.17% of the company’s stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Featured Article: Why do earnings reports matter?

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.